Q1 2018 13F Holders as of 3/31/2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Number of holders
-
81
-
Total 13F shares, excl. options
-
43.5M
-
Shares change
-
+11.7M
-
Total reported value, excl. options
-
$707M
-
Value change
-
+$188M
-
Put/Call ratio
-
0.22
-
Number of buys
-
58
-
Number of sells
-
-38
-
Price
-
$16.23
Significant Holders of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) as of Q1 2018
107 filings reported holding GLYC - GLYCOMIMETICS INC - Common Stock, par value $0.001 per share as of Q1 2018.
GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) has 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43.5M shares
.
Largest 10 shareholders include NEA Management Company, LLC (8.58M shares), WELLINGTON MANAGEMENT GROUP LLP (5.79M shares), FMR LLC (3.47M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.87M shares), OppenheimerFunds, Inc. (2.5M shares), Redmile Group, LLC (2.28M shares), FRANKLIN RESOURCES INC (2.11M shares), STATE STREET CORP (1.69M shares), JENNISON ASSOCIATES LLC (1.57M shares), and VANGUARD GROUP INC (1.52M shares).
This table shows the top 81 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.